Clinical Trial Update: Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether alpha tocopherol can prevent contrast-induced nephropathy in patients with chronic kidney disease; no results or statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Contrast-induced Nephropathy

Drugs mentioned

• Alpha-tocopherol (alpha-tocopherol)

Snippet

Sponsor: Thammasat University | Conditions: Contrast Induced Nephropathy | Phase 3 | Status: UNKNOWN